Nippon Kayaku CoFRA:NP7 -0.90%84 EBITDA Margin % is 0.86% as of Dec. 2025, which is 95% below its 10-year median of 18.66. GuruFocus rates FRA:NP7 with a GF Score™ of 84/100 and a GF Value™ of €9.08 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 1,584 Chemicals companies, Nippon Kayaku Co ranks better than 83.59% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Nippon Kayaku Co's EBITDA for the
three
months ended in Dec. 2025 was €3 Mil. Nippon Kayaku Co's Revenue for the
three
months ended in Dec. 2025 was €334 Mil. Therefore, Nippon Kayaku Co's EBITDA margin for the quarter that ended in Dec. 2025 was 0.86%.
Nippon Kayaku Co (FRA:NP7) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Nippon Kayaku Co EBITDA Margin % Related Terms
Nippon Kayaku Co EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Nippon Kayaku Co's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, Nippon Kayaku Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nippon Kayaku Co EBITDA Margin % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Nippon Kayaku Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Nippon Kayaku Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nippon Kayaku Co (FRA:NP7) has a EBITDA Margin % of 0.86% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Nippon Kayaku Co and its competitors. This is 95% below median its historical median of 18.66. Over the past decade, Nippon Kayaku Co's EBITDA Margin % has ranged from 10.77 to 21.29. According to the industry distribution chart, Nippon Kayaku Co ranks #260 out of 1584 companies in the Chemicals industry, placing it in the top 16.4%.
Is Nippon Kayaku Co's EBITDA Margin % too high?
Nippon Kayaku Co's current EBITDA Margin % of 0.86% is 95% below median its 10-year median of 18.66. Over the past 10 years, this metric has ranged from a low of 10.77 to a high of 21.29. The Chemicals industry median EBITDA Margin % is 9.64. Nippon Kayaku Co's value of 0.86% is 91.1% below this industry median. Based on the distribution chart, Nippon Kayaku Co ranks #260 out of 1584 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Nippon Kayaku Co has a GF Score™ of 84/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Nippon Kayaku Co's EBITDA Margin % compare to DOW?
According to the Chemicals industry distribution chart, Nippon Kayaku Co ranks #260 out of 1584 companies for EBITDA Margin %. This places Nippon Kayaku Co in the top 16% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 9.64. Nippon Kayaku Co's value of 0.86% is 91.1% below this benchmark. Historically, Nippon Kayaku Co's own EBITDA Margin % has ranged from 10.77 to 21.29 over the past decade. While the company's 10-year median is 18.66 vs. the industry median of 9.64, Nippon Kayaku Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Chemicals company?
The median EBITDA Margin % among Chemicals companies is 9.64, based on 1,584 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nippon Kayaku Co's current EBITDA Margin % of 0.86% is 91.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Nippon Kayaku Co and its competitors. For the Chemicals industry, the median EBITDA Margin % is 9.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nippon Kayaku Co's current EBITDA Margin % is 0.86%, which is 95% below median its own 10-year median of 18.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nippon Kayaku Co stock overvalued right now?
Based on GuruFocus' analysis, Nippon Kayaku Co (FRA:NP7) is currently considered Modestly Overvalued. The stock's GF Value™ is €9.08, compared to a current price of €11.00 — trading 21.1% above its estimated fair value. The current EBITDA Margin % is 0.86%, which is 95% below median its 10-year median of 18.66 and 91.1% below the Chemicals industry median of 9.64. Nippon Kayaku Co's overall GF Score™ is 84/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Nippon Kayaku Co (FRA:NP7), the current EBITDA Margin % is 0.86% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nippon Kayaku Co (FRA:NP7) Overvalued in 2026?
Based on GuruFocus' analysis, Nippon Kayaku Co stock appears to be overvalued.
The current stock price of €11.00 is trading 21.1% above its estimated GF Value™ of €9.08.
GuruFocus considers Nippon Kayaku Co to be Modestly Overvalued.
Key valuation signals for FRA:NP7:
EBITDA Margin %: 0.86% (95% below median its 10-year median of 18.66)
GF Value™: €9.08 vs. price of €11.00 (21.1% above fair value)
Industry Position: 91.1% below the Chemicals median (#260 of 1584)
No single metric tells the full story. See the FRA:NP7 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nippon Kayaku Co Ltd manufactures and sells a variety of chemicals. The firm organizes itself into four segments based on product type. The functional chemicals segment, which generates more revenue than any other segment, sells epoxy resins used as flame retardants in electronics, colorants and dyes used in inkjet printers and the manufacture of textiles. The pharmaceuticals segment sells anti-cancer drugs, biological drugs, cardiovascular agents, vitamin compounds, and anti-inflammatory agents. The safety systems segment sells airbag inflators and micro gas generators for seatbelt pretensioners to the automotive industry, both of which are used to protect passengers during an accident. The agrochemicals segment sells insecticides and herbicides. The majority of revenue comes from Asia.
84GF Score
Get the complete analysis for FRA:NP7
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:NP7 has been successfully added to your 
